Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in FH cause hereditary leiomyomatosis and renal cell cancer (HLRCC) (7).”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [7]
In the citing paper
“Familial cancer syndromes caused by fumarate hydratase (FH) or succinate dehydrogenase (SDH) deletion suggest that these TCA enzymes can behave as classical tumor suppressors.”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Tomlinson et al., 2002
In the citing paper
“Similarly, germline mutations in the broadly expressed enzyme fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma, a familial syndrome of uterine and cutaneous leiomyomas and kidney cancer, without susceptibility to more common tumors (11).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [11]
In the citing paper
“In 2001, mutation of fumarate hydratase leading to its inactivation was discovered in renal cell cancer129. Mutation of this enzyme leads to fumarate accumulation not only in skin cancer and uterine leiomyomas but also in breast, bladder, and Leydig cell tumors130.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [130]
In the citing paper
“Consistently, heterozygous germline mutations in genes encoding the TCA cycle enzymes involved in the breakdown of these metabolites—SDH and FH—have been shown to facilitate the pathogenesis of certain rare cancers (e.g., paragangliomas) and inherited cancer-predisposition syndromes (181, 182, 183).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [183]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Inherited susceptibility to uterine leiomyomas and renal cell cancer
Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633798 · Cited by 669
Fumarase C, the stable fumarase of Escherichia coli, is controlled by the soxRS regulon.
Liochev, S. I., & Fridovich, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5892 · Cited by 239
The VHL tumour-suppressor gene paradigm
Kaelin, W. G., & Maher, E. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01558-3 · Cited by 213 · cited 1×
“, individuals with von Hippel–Lindau syndrome are predisposed to both phaeochromocytomas and renal carcinoma”
BackgroundKiuru, M., Launonen, V., Hietala, M., Aittomäki, K., Vierimaa, O., Salovaara, R., Arola, J., Pukkala, E., Sistonen, P., Herva, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61757-9 · Cited by 209
Bourgeron, T., Chretien, D., Poggi-Bach, J., Doonan, S., Rabier, D., Letouzé, P., Munnich, A., Rötig, A., Landrieu, P., & Rustin, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117261 · Cited by 160
Alam, N. A., Bevan, S., Churchman, M., Barclay, E., Barker, K., Jaeger, E. E. M., Nelson, H. M., Healy, E., Pembroke, A. C., Friedmann, P. S., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/320124 · Cited by 160
Familial predisposition to uterine leiomyomas
Vikhliaeva, E. M., Сагдуллаевна, Х. З., & Nd, F. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02533-i · Cited by 152 · cited 1×
“gif" NDATA ITEM> ]> Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesi”
Background
Cited by
Items 301–400 of 1,000
On the association of succinate dehydrogenase mutations with hereditary paraganglioma
Baysal, B. E. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.004 · Cited by 106
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
Erez, A., & DeBerardinis, R. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3949 · Cited by 105
He, X., Yan, B., Liu, S., Jia, J., Lai, W., Xing, X., Tang, C., Luo, D., Tan, T., Jiang, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0268 · Cited by 112
“Although FH was discovered as a tumor suppressor (46), the regulators of this important TCA cycle enzyme and the consequences of FH downregulation remain unclear.”
BackgroundStewart, L., Glenn, G. M., Stratton, P., Goldstein, A. M., Merino, M. J., Tucker, M. A., Linehan, W. M., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archdermatol.2008.517 · Cited by 111
Yang, Y., Lane, A. N., Ricketts, C. J., Sourbier, C., Wei, M.-H., Shuch, B., Pike, L., Wu, M., Rouault, T. A., Boros, L. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072179 · Cited by 103
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Zheng, L., MacKenzie, E. D., Karim, S. A., Hedley, A., Blyth, K., Kalna, G., Watson, D. G., Szlosarek, P., Frezza, C., & Gottlieb, E. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-12 · Cited by 103
Molecular and Cellular Insights into the Development of Uterine Fibroids
Machado-Lopez, A., Simón, C., & Mas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168483 · Cited by 113
“HLRCC is caused by germline mutations in the fumarate hydratase (FH) gene, which encodes an enzyme involved in the tricarboxylic acid cycle with a tumor suppressor role [48,49].”
BackgroundRenal cell carcinoma: Current status and emerging therapies
Nelson, E. C., Evans, C. P., & Lara, P. N. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.12.005 · Cited by 103
The contribution of mitochondria to common disorders
Enns, G. M. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.009 · Cited by 112
Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
Alrezk, R., Suárez, A., Tena, I., & Pacák, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00515 · Cited by 105
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
Xiao, Y., & Meierhofer, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153672 · Cited by 107
Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype
Cervera, A. M., Apostolova, N., Crespo, F. L., Mata, M., & McCreath, K. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5580 · Cited by 98
“fourth TCA cycle tumor suppressor gene (6).”
Electron transport chain inhibition increases cellular dependence on purine transport and salvage
Wu, Z., Bezwada, D., Cai, F., Harris, R. C., Ko, B., Sondhi, V., Pan, C., Vu, H., Nguyen, P. T., Faubert, B., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.014 · Cited by 108
“Some of these same enzymes, including succinate dehydrogenase and fumarate hydratase, are tumor suppressors in adult-onset cancers 6–8 .”
BackgroundPollard, P., Wortham, N., Barclay, E., Alam, A., Elia, G., Manek, S., Poulsom, R., & Tomlinson, I. (2005) · The Journal of Pathology · doi:10.1002/path.1686 · Cited by 100
“The second condition, hereditary leiomyomatosis and renal cell cancer (HLRCC, or cutaneous and uterine leiomyomatosis), occurs as a result of mutations in fumarate hydratase (FH ) [5].”
BackgroundSelf-citationHoekstra, A. S., de Graaff, M. A., Briaire-de Bruijn, I. H., Ras, C., Seifar, R. M., van Minderhout, I., Cornelisse, C. J., Hogendoorn, P. C. W., Breuning, M. H., Suijker, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6091 · Cited by 99
“Inactivating germline mutations of FH result in hereditary leiomyomatosis and renal cell carcinoma (HLRCC), which is inherited in an autosomal dominant manner [7, 8].”
BackgroundThe multifaceted contribution of α-ketoglutarate to tumor progression: An opportunity to exploit?
Abla, H., Sollazzo, M., Gasparre, G., Iommarini, L., & Porcelli, A. M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.031 · Cited by 102
Glunde, K., Jiang, L., Moestue, S. A., & Gribbestad, I. S. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1751 · Cited by 100
Reyes, C., Karamurzin, Y. S., Frizzell, N., Garg, K., Nonaka, D., Chen, Y., & Soslow, R. A. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.215 · Cited by 101
“3q43, where the FH gene is located (4, 6-9).”
BackgroundInfluentialMetabolic alterations in renal cell carcinoma
Massari, F., Ciccarese, C., Santoni, M., Brunelli, M., Piva, F., Modena, A., Bimbatti, D., Fantinel, E., Santini, D., Cheng, L., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.07.002 · Cited by 107
“nizable as a cytosolic form thought to be involved in amino acid metabolism [51].”
BackgroundMiettinen, M., Felisiak-Gołąbek, A., Wasąg, B., Chmara, M., Wang, Z., Bützow, R. C., & Lasota, J. P. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000703 · Cited by 101
“(3) Epithelioid leiomyomas were SMTs with distinctly epithelioid cytology/epithelioid component (n=61).”
BackgroundMutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy
Ait-El-Mkadem, S., Dayem, M. A., Gušić, M., Chaussenot, A., Bannwarth, S., François, B., Genin, E. C., Fragaki, K., Volker‐Touw, C. M. L., Vasnier, C., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.014 · Cited by 99
Malic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis
Wang, Y.-P., Sharda, A., Xu, S., van Gastel, N., Man, C. H., Choi, U., Leong, W. Z., Li, X., & Scadden, D. T. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.003 · Cited by 101
A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia
Adam, J., Yang, M., Bauerschmidt, C., Kitagawa, M., O’Flaherty, L., Maheswaran, P., Özkan, G., Sahgal, N., Baban, D., Kato, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.006 · Cited by 97
Liu, X., Si, W., He, L., Yang, J., Peng, Y., Ren, J., Liu, X., Jin, T., Yu, H., Zhang, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00774-2 · Cited by 97
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 102
The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer
Ciccarone, F., Vegliante, R., Leo, L. D., & Ciriolo, M. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.008 · Cited by 100
Genetic defects in fatty acid β‐oxidation and acyl‐CoA dehydrogenases
Gregersen, N., Bross, P., & Andresen, B. S. (2004) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03949.x · Cited by 97
Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects
Tyrakis, P. A., Yurkovich, M. E., Sciacovelli, M., Papachristou, E. K., Bridges, H. R., Gaude, E., Schreiner, A., D’Santos, C. S., Hirst, J., Hernandez-Fernaud, J. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.092 · Cited by 105
Forde, C., Lim, D., Alwan, Y., Burghel, G. J., Butland, L., Cleaver, R., Dixit, A., Evans, D. G., Hanson, H., Lalloo, F. I., et al. (2019) · European Urology Oncology · doi:10.1016/j.euo.2019.11.002 · Cited by 109
Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory
Collins, R. R. J., Patel, K., Putnam, W. C., Kapur, P., & Rakheja, D. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.267666 · Cited by 90
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
Ferro, M., Musi, G., Marchioni, M., Maggi, M., Veccia, A., Giudice, F. D., Barone, B., Crocetto, F., Lasorsa, F. M., Antonelli, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054615 · Cited by 109
A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology
Acker, T., & Plate, K. H. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0355-1 · Cited by 112
“It was subsequently shown that the HIF system is constitutively activated in RCC lacking a functional pVHL. Loss of pVHL function leads to stabilization of HIF-α subunits already under normoxic conditions, while reintroduction of a functional VHL gene restored HIF regulation [33, 59].”
BackgroundInfluentialEstèves, P., Pecqueur, C., Ransy, C., Esnous, C., Lenoir, V., Bouillaud, F., Bulteau, A., Lombès, A., Prip‐Buus, C., Ricquier, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3383 · Cited by 95
Reitman, Z. J., Duncan, C. G., Poteet, E., Winters, A., Yan, L.-J., Gooden, D. M., Spasojevic, I., Boros, L. G., Yang, S.-H., & Yan, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575183 · Cited by 86
Biochemical Assays for Mitochondrial Activity: Assays of TCA Cycle Enzymes and PDHc
Saada, A., & Elpeleg, O. N. (2007) · Methods in cell biology · doi:10.1016/s0091-679x(06)80010-5 · Cited by 102
Pseudohypoxic Pathways in Renal Cell Carcinoma
Bratslavsky, G., Sudarshan, S., Neckers, L., & Linehan, W. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2510 · Cited by 89
Alam, M. M., Lal, S., FitzGerald, K. E., & Li, Z. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0082-9 · Cited by 100
“Mutations in the FH gene were first identified in inherited uterine fibroids, skin leiomyoma, and papillary renal cell cancer by a combination of mapping methods [84].”
BackgroundVälimäki, N., Kuisma, H., Pasanen, A. M., Heikinheimo, O., Sjöberg, J., Bützow, R. C., Sarvilinna, N. S., Heinonen, H.-R., Tolvanen, J., Bramante, S., et al. (2018) · eLife · doi:10.7554/elife.37110 · Cited by 98
Hereditary Paraganglioma/Pheochromocytoma and Inherited Succinate Dehydrogenase Deficiency
Favier, J., Brière, J.-J., Strompf, L., Amar, L., Filali, M., Jeunemaitre, X., Rustin, P., & Gimenez-Roqueplo, A.-P. (2005) · Hormone Research in Paediatrics · doi:10.1159/000084685 · Cited by 88
Ordulu, Z., Cin, P. D., Chong, W., Choy, K. W., Lee, C., Muto, M. G., Quade, B. J., & Morton, C. C. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20824 · Cited by 93
“FH appears to act as a tumor suppressor and follow the classic Knudson ‘‘two-hit’’ model as LOH was found in the tumors of affected individuals (Tomlinson et al., 2002; Alam et al., 2003).”
BackgroundMolecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer
Tran, T. Q., Lowman, X. H., & Kong, M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2506 · Cited by 103
“For example, loss-of-function mutations in the succinate dehydrogenase (SDH) gene and the fumarate hydratase (FH) gene are found in a number of human cancers that lead to rapid accumulation of succinate or fumarate (26, 27).”
BackgroundRare insights into cancer biology
Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 92
Heme oxygenase inhibition in cancers: possible tools and targets
Podkalicka, P., Mucha, O., Józkowicz, A., Dulak, J., & Łoboda, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73879 · Cited by 94
Genetically-defined metabolic reprogramming in cancer
Mullen, A. R., & DeBerardinis, R. J. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.009 · Cited by 86
“As in the familial forms of PCC and PGL, individuals with HLRCC inherit one loss of function allele and somatically lose the other allele in the tumors.”
BackgroundInfluentialEndocrine-disrupting chemicals and uterine fibroids
Katz, T. A., Yang, Q., Treviño, L. S., Walker, C. L., & Al-Hendy, A. A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.023 · Cited by 91
Chicken or the egg: Warburg effect and mitochondrial dysfunction
Senyilmaz, D., & Teleman, A. A. (2015) · F1000Prime Reports · doi:10.12703/p7-41 · Cited by 97
DNA Methylation: From Cancer Biology to Clinical Perspectives
Chen, C., Wang, Z., Ding, Y., Wang, L., Wang, S., Wang, H., & Qin, Y. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2712326 · Cited by 95
Nuclear genes in mitochondrial disorders
Zeviani, M., Spinazzola, A., & Carelli, V. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00052-2 · Cited by 98
Gleeson, J. P., Nikolovski, I., DiNatale, R. G., Zucker, M. R., Knežević, A., Patil, S., Ged, Y. M. A., Kotecha, R. R., Shapnik, N., Murray, S. J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4367 · Cited by 92
“The syndrome is caused by heterozygous mutations to the FH gene, which encodes FH, a critical component of the Krebs cycle (2, 3).”
BackgroundStructural basis of fumarate hydratase deficiency
Picaud, S., Kavanagh, K. L., Yue, W. W., Lee, W. H., Müller, S., Gileadi, O., Sacchettini, J. C., & Oppermann, U. C. T. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9294-8 · Cited by 92
“Interestingly, whereas homozygous FH mutations predispose to fumaric aciduria, several heterozygous FH mutations are known to be involved in the autosomal dominant syndrome of multiple cutaneous and uterine leiomyomata (MCUL1) (Tomlinson et al. 2002).”
BackgroundInfluentialYlisaukko‐oja, S. K., Kiuru, M. H., Lehtonen, H. J., Lehtonen, R., Pukkala, ., Arola, J. T., Launonen, V., & Aaltonen, L. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21798 · Cited by 88
“The FH activity in lymphoblastoid cell lines from HLRCC patients with heterozygous FH mutation is reduced as compared with controls.(10,13,17) Of note, lymphoblastoid cell lines with missense mutation tend to have a lower enzyme activity than deletion/truncating mutants, probably due to a dominant negative action of t…”
BackgroundResultMitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 90
“FH (loss-of-function) Fumarate Decreased flux of metabolites through the Krebs cycle Impaired oxidative metabolism Increased glutamine uptake and lactate production Accumulation of fumarate-derived argininosuccinate Acquired auxotrophy for arginine Bilirubin excretion Inhibition of α-KGdependent dioxygenases (KDMs, TE…”
The Hypoxia-Inducible Factor and Tumor Progression Along the Angiogenic Pathway
Brahimi-Horn, M. C., & Pouysségur, J. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42004-x · Cited by 99
Familial risk of cancer by site and histopathology
Hemminki, K., & Li, X. (2002) · International Journal of Cancer · doi:10.1002/ijc.10764 · Cited by 87
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions
Guitart, A. V., Panagopoulou, T. I., Villacreces, A., Vukovic, M., Sepulveda, C., Allen, L., Carter, R. N., van de Lagemaat, L. N., Morgan, M., Giles, P., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161087 · Cited by 86
Clinical and molecular progress in hereditary paraganglioma: Figure 1
Baysal, B. E. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058560 · Cited by 86
“More recently, mutations in the fumarate hydratase protein (FH; fumarase), which hydrates fumarate to malate in the Krebs cycle, was also linked to an inherited tumour syndrome characterised by the development of leiomyomata of uterus and skin and renal cancer (HLRCC).(38) How mutations in these mitochondrial genes ca…”
BackgroundCrooks, D. R., Maio, N., Lang, M., Ricketts, C. J., Vocke, C. D., Gurram, S., Turan, S., Kim, Y., Cawthon, G. M., Sohelian, F., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc4436 · Cited by 87
Marelli‐Berg, F. M., Fu, H., & Mauro, C. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03583.x · Cited by 92
Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma
Okuda, H., Toyota, M., Ishida, W., Furihata, M., Tsuchiya, M., Kamada, M., Tokino, T., & Shuin, T. (2005) · Oncogene · doi:10.1038/sj.onc.1209200 · Cited by 86
“Recently, the fumarate hydratase (FH) and Bert Hogg Dube (BHD) genes were identified by positional cloning as candidate tumor suppressor genes in RCC, but they appear to mainly participate in the development of hereditary human RCC (Nickerson et al., 2002; Tomlinson et al., 2002).”
BackgroundSrirangalingam, U., Walker, L., Khoo, B. C. E., MacDonald, F., Gardner, D. S.-L., Wilkin, T. J., Skelly, R. H., George, E., Spooner, D. A., Monson, J. P., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03274.x · Cited by 93
Laurenti, G., & Tennant, D. A. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160099 · Cited by 91
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
Ooi, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.016 · Cited by 90
“Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), a hereditary cancer syndrome that follows an autosomal dominant inheritance pattern with incomplete penetrance.[5] The two diseases have very distinct manifestations: The age of onset for fumarate hydratase deficiency is during the neonatal to early infantile pe…”
BackgroundInfluentialMED12 exon 2 mutations in histopathological uterine leiomyoma variants
Mäkinen, N., Vahteristo, P., Kämpjärvi, K., Arola, J. T., Bützow, R. C., & Aaltonen, L. A. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.33 · Cited by 85
The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism
Meng, Y., Xu, X. J., Luan, H., Li, L., Dai, W., Li, Z., & Bian, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0052 · Cited by 89
Emerging Metabolic Targets in Cancer Therapy
Zhao, Y., Liu, H., Riker, A. I., Fodstad, Ø., LeDoux, S. P., Wilson, G. L., & Tan, M. (2010) · Frontiers in bioscience · doi:10.2741/3826 · Cited by 90
“There also may be substitutions or deletions of highly conserved amino acids, which eventually result in the absence or inhibition of FH enzymatic activity (56).”
BackgroundAdrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer
Shuch, B., Ricketts, C. J., Vocke, C. D., Valera, V. A., Chen, C. C., Gautam, R., Gupta, G. N., Gomez Macias, G. S., Merino, M. J., Bratslavsky, G., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.07.139 · Cited by 79
Bükülmez, O., & Doody, K. J. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2005.12.002 · Cited by 83
“gene [72].”
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
Pecqueur, C., Oliver, L., Oizel, K., Lalier-Bretaudeau, L., & Vallette, F. M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/805975 · Cited by 92
“Two major classes of mutations occur in genes required for the function of the TCA cycle enzymes namely the succinate dehydrogenase (SDHA, SDHB, SDHC, SDHD, and SDHAF2) and the fumarate hydratase (FH) [25, 26].”
BackgroundGenetic heterogeneity among uterine leiomyomata: insights into malignant progression
Hodge, J. C., & Morton, C. C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm043 · Cited by 83
Interactions between epigenetics and metabolism in cancers
Yun, J., Johnson, J. L., Hanigan, C. L., & Locasale, J. W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00163 · Cited by 82
“Furthermore, metabolic enzymes such as succinate dehydrogenase (SDH), fumarate hydratase (FH), isocitrate dehydrogenases 1/2 (IDH1/2) and phosphoglycerate dehydrogenase (PHGDH) have been reported to be genetically altered in various tumors (Baysal et al., 2000; Tomlinson et al., 2002; Parsons et al., 2008; Locasale et…”
BackgroundEmerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy
Zhu, Y., Dean, A. E., Horikoshi, N., Heer, C. D., Spitz, D. R., & Gius, D. R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120844 · Cited by 85
Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential
Ip, P. P. C., & Cheung, A. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.07.003 · Cited by 82
Shao, Y., Ye, G., Ren, S., Piao, H., Zhao, X., Lu, X., Wang, F., Ma, W., Li, J. X., Yin, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31313 · Cited by 89
Xiao, Y., Elkins, K., Durieux, J. K., Lee, L., Oeh, J., Yang, L. X., Liang, X., DelNagro, C., Tremayne, J., Kwong, M., et al. (2013) · Neoplasia · doi:10.1593/neo.131304 · Cited by 80
“[3] Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, et al.”
BackgroundMutations in Exon 1 Highlight the Role ofMED12in Uterine Leiomyomas
Kämpjärvi, K., Park, M. J., Mehine, M. M., Kim, N. H., Clark, A. D., Bützow, R. C., Böhling, T., Böhm, J., Mecklin, J., Järvinen, H., et al. (2014) · Human Mutation · doi:10.1002/humu.22612 · Cited by 81
Buelow, B., Cohen, J. N., Nagymányoki, Z., Frizzell, N., Joseph, N. M., McCalmont, T. H., & Garg, K. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000626 · Cited by 84
Pérez-Rambla, C., Puchades‐Carrasco, L., García-Flores, M., Rubio‐Briones, J., López‐Guerrero, J. A., & Pineda‐Lucena, A. (2017) · Metabolomics · doi:10.1007/s11306-017-1194-y · Cited by 87
Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
Schaap, F. G., French, P. J., & Bovée, J. V. M. G. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31827b654d · Cited by 84
Looi, K., Nakayasu, E. S., de Diaz, R. A., Tan, E. M., de Almeida, I. C., & Zhang, J.-Y. (2008) · Journal of Proteome Research · doi:10.1021/pr800273h · Cited by 80
Mass spectrometry and the search for moonlighting proteins
Jeffery, C. J. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20041 · Cited by 79
Metabolism of Kidney Cancer: From the Lab to Clinical Practice
Sudarshan, S., Karam, J. A., Brugarolas, J., Thompson, R. H., Uzzo, R. G., Rini, B. I., Margulis, V., Patard, J., Escudier, B. J., & Linehan, W. M. (2012) · European Urology · doi:10.1016/j.eururo.2012.09.054 · Cited by 85
“However, the report of genetic predisposition to type 2 pRCC of patients with germline mutations of the fumarate hydratase (FH) gene led to further understanding of the metabolic aspect of this disease [53].”
BackgroundMetabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 87
Shuch, B. M., Singer, E. A., & Bratslavsky, G. (2012) · Urologic Clinics of North America · doi:10.1016/j.ucl.2012.01.006 · Cited by 78
Disorders of mitochondrial function
Debray, F., Lambert, M. A., & Mitchell, G. A. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328306ebb6 · Cited by 96
Halder, S. K., Laknaur, A., Miller, J. K., Layman, L. C., Diamond, M. P., & Al-Hendy, A. A. (2014) · Molecular Genetics and Genomics · doi:10.1007/s00438-014-0938-x · Cited by 77
A Comparative Proteomic Strategy for Subcellular Proteome Research
Jiang, X.-S., Dai, J., Sheng, Q., Zhang, L., Xia, Q., Wu, J., & Zeng, R. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400079-mcp200 · Cited by 82
Lee, J. P., Brauweiler, A., Rudolph, M., Hooper, J. E., Drabkin, H. A., & Gemmill, R. M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0491 · Cited by 76
“These include fumarate hydratase and succinate dehydrogenase (5, 6), which affect HIFα”
BackgroundLussey‐Lepoutre, C., Bellucci, A., Morin, A., Buffet, A., Amar, L., Janin, M., Ottolenghi, C., Zinzindohoué, F., Autret, G., Burnichon, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1576 · Cited by 84
“Since then, mutations in genes encoding for the TCA enzymes fumarate hydratase (FH) (7), isocitrate dehydrogenase (IDH1 and 2) (8) and more recently malate dehydrogenase (MDH2), were reported to predispose to PPGL, renal cancers, leimyomas, or to be causative of sporadic gliomas (for review, (9)).”
BackgroundThe Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 84
Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer
Tan, D., Chang, J., Liu, L., Bai, R., Wang, Y., Yeh, K., & Wong, L. C. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-93 · Cited by 74
“The identification of tumor suppressing functions of several genes that are involved in energy metabolism [14-18] and the role of the mitochondria in apoptotic pathways [19], have suggested that mtDNA alterations might be an important integral of tumorigenesis and programmed cell death.”
BackgroundKoeman, J. M., Russell, R. C., Tan, M., Petillo, D., Westphal, M., Koelzer, K., Metcalf, J. L., Zhang, Z., Matsuda, D., Dykema, K. J., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000176 · Cited by 74
“The disruption of HIF activity has been associated with kidney cancer related to VHL disease, sporadic clear cell RCC, and hereditary papillary RCC [38,41,42].”
BackgroundClinical genomics of renal epithelial tumors
Hagenkord, J. M., Gatalica, Z., Jonasch, E. W., & Monzon, F. A. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.06.001 · Cited by 77
“The majority of mutations in FH are point mutations or small deletions/insertions (50,51), although exonic and whole-gene deletions have been reported (53,54).”
BackgroundNovel Role of Fumarate Metabolism in Dahl-Salt Sensitive Hypertension
Tian, Z., Liu, Y. U., Usa, K., Mladinov, D., Fang, Y., Ding, X., Greene, A. S., Cowley, A. W., & Liang, M. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129528 · Cited by 74
Badeloe, S., van Geel, M., Steensel, M. A. M. V., Bastida, J., Ferrando, J., Steijlen, P. M., Frank, J., & Poblete‐Gutiérrez, P. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00470.x · Cited by 74
“If such studies were carried out, they consisted of demonstrating reduced FH activity in lymphoblastoid cell lines from patients with these missense mutations when compared with control cell lines (9,10).”
BackgroundAlam, N. A., Olpin, S. E., Rowan, A., Kelsell, D. P., Leigh, I. M., Tomlinson, I. P. M., & Weaver, T. M. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60574-0 · Cited by 74
“MCUL/HLRCC has been found to be caused by germline mutations in fumarate hydratase (FH) in the majority of screened cases.(1,5,6) Forty-six distinct FH mutations have been reported to date in MCUL/HLRCC.”
BackgroundRenal cancer in von Hippel–Lindau disease and related syndromes
Bausch, B., Jilg, C. A., Gläsker, S., Vortmeyer, A. O., Lützen, N., Anton, A., Eng, C., & Neumann, H. P. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.144 · Cited by 79
Valle-Mendiola, A., & Soto-Cruz, I. (2020) · Cancers · doi:10.3390/cancers12010124 · Cited by 72
Metabolic adaptations in prostate cancer
Pujana-Vaquerizo, M., Bozal‐Basterra, L., & Carracedo, A. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02762-z · Cited by 98
MED12 mutation frequency in unselected sporadic uterine leiomyomas
Heinonen, H.-R., Sarvilinna, N. S., Sjöberg, J., Kämpjärvi, K., Pitkänen, E., Vahteristo, P., Mäkinen, N., & Aaltonen, L. A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.06.040 · Cited by 79
Metabolic reprogramming and disease progression in cancer patients
Torresano, L., Nuevo‐Tapioles, C., Santacatterina, F., & Cuezva, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165721 · Cited by 75
Metadata
- Authors
- The Multiple Leiomyoma Consortium
- Venue
- Nature Genetics
- Published
- 2002-02-25
- Volume
- 30
- Issue
- 4
- Pages
- 406-410
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1967291345
- Cited by
- 1,635
- References
- 17
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 64 · 2023: 57 · 2022: 65 · 2021: 80 · 2020: 93 · 2019: 86 · 2018: 81 · 2017: 90 · 2016: 106 · 2015: 89 · 2014: 85 · 2013: 82 · 2012: 82
- FWCI
- 56.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- U.S. Public Health Service (U59309)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- fumarate hydratase, FH gene, germline mutations, uterine fibroids, cutaneous leiomyoma, papillary renal cell carcinoma, cancer susceptibility, tumor suppressor, fumarate hydratase deficiency, compound heterozygosity, TCA cycle, fibroid pathogenesis
- MeSH terms
- Alleles, Carcinoma, Papillary, Carcinoma, Renal Cell, Chromosomes, Human, Pair 1, Exons, Female, Fumarate Hydratase, Genes, Dominant, Genetic Markers, Humans, Kidney Neoplasms, Leiomyoma, Male, Mutation, Pedigree, Recombination, Genetic, Uterine Neoplasms, Gene Deletion, In Situ Hybridization, Fluorescence, Sequence Analysis, DNA, Germ-Line Mutation, Leiomyoma, Epithelioid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.